NCT01645475View on ClinicalTrials.gov

Desmopressin Melt: Impact on Sleep and Daytime Functioning

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Monosymptomatic Nocturnal Enuresis

Interventions

DRUG

Desmopressin lyophilisate (Melt)

Patient receives Desmopressin lyophilisate (Melt).

Trial Locations (1)

9000

Ghent University Hospital, Ghent

Sponsors

Collaborators (1)

Ferring Pharmaceuticals

All Listed Sponsors

collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

University Hospital, Ghent

OTHER

NCT01645475 - Desmopressin Melt: Impact on Sleep and Daytime Functioning | Biotech Hunter | Biotech Hunter